Sodium glucose cotransporter 2 inhibitors treatment in acromegalic patients with diabetes—a case series and literature review
Author:
Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Link
https://link.springer.com/content/pdf/10.1007/s12020-021-02718-w.pdf
Reference34 articles.
1. L. Katznelson, E.R. Laws, S. Melmed et al. Acromegaly: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 99, 3933–3951 (2014)
2. M.R. Gadelha, L. Kasuki, D.S.T. Lim, M. Fleseriu, Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr. Rev. 40, 268–332 (2019)
3. B. Zinman, C. Wanner, J.M. Lachin,EMPA-REG OUTCOME Investigators et al., Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N. Engl. J. Med. 373, 2117–2128 (2015)
4. J.J.V. McMurray, D.L. DeMets, S.E. Inzucchi, L. Køber, M.N. Kosiborod, A.M. Langkilde, F.A. Martinez, O. Bengtsson, P. Ponikowski, M.S. Sabatine, M. Sjöstrand, S.D. Solomon,DAPA-HF Committees and Investigators, A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF). Eur. J. Heart Fail. 21, 665–675 (2019)
5. C. Wanner, H.J.L. Heerspink, B. Zinman, S.E. Inzucchi, A. Koitka-Weber, M. Mattheus, S. Hantel, H.J. Woerle, U.C. Broedl, M. von Eynatten, P.H. Groop,EMPA-REG OUTCOME Investigators, Empagliflozin and kidney function decline in patients with type 2 diabetes: a slope analysis from the EMPA-REG OUTCOME trial. J. Am. Soc. Nephrol. 29, 2755–2769 (2018)
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Management of Diabetes Mellitus in Acromegaly and Cushing’s Disease with Focus on Pasireotide Therapy: A Narrative Review;Diabetes, Metabolic Syndrome and Obesity;2024-07
2. Diabetes mellitus in patients with acromegaly: pathophysiology, clinical challenges and management;Nature Reviews Endocrinology;2024-06-06
3. Management of pasireotide-induced hyperglycemia in patients with acromegaly: An experts’ consensus statement;Frontiers in Endocrinology;2024-02-09
4. Diabetes mellitus in acromegaly: prevalence, pathophysiological particulars and treatment strategies;Almanac of Clinical Medicine;2023-12-09
5. Acromegalic Cardiomyopathy: An Entity on its own? The Effects of GH and IGF-I Excess and Treatment on Cardiovascular Risk Factors;Archives of Medical Research;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3